Advertisement
US Stocks

PATH Stock Down 1.2% in Pre-Market: UiPath Inc. (NYSE) at $10.66

Key Points

UiPath (PATH) trades at $10.66, down 1.2% in pre-market on NYSE.

Meyka AI rates PATH with B+ grade reflecting strong fundamentals and growth potential.

Analyst consensus is Hold with $14.07 average price target, implying 32% upside.

Earnings announcement scheduled for May 28, 2026, could serve as major catalyst.

Be the first to rate this article

UiPath Inc. (PATH) opened pre-market trading at $10.66 USD on the NYSE, down 1.2% from the previous close of $10.79. The automation software leader faces headwinds as institutional investors weigh macro risks against strong fundamentals. With a market cap of $5.73 billion and trading volume of 36.6 million shares, PATH stock continues to attract attention from both bulls and bears. Meyka AI rates PATH stock with a B+ grade, reflecting solid long-term potential despite recent volatility. Today’s pre-market session shows cautious sentiment as traders await earnings on May 28.

Advertisement

PATH Stock Performance and Market Sentiment

UiPath Inc. (PATH) trades near its 50-day moving average of $10.97, showing consolidation after a challenging year. The stock has fallen 35% year-to-date but gained 13.6% over the past month, signaling potential recovery momentum. Pre-market volume of 36.6 million shares exceeds the 30-day average of 31.4 million, indicating active institutional participation.

Trading Activity and Liquidation Dynamics

Institutional ownership stands at 62.5% with $1.74 billion in inflows over the past 12 months. However, short interest has climbed to 28.6% of the public float, representing 115 million shares sold short. This elevated short interest suggests skepticism about near-term recovery, though it also creates potential for a squeeze if sentiment shifts. The short interest ratio of 5.2 days indicates moderate covering pressure.

Financial Metrics and Valuation Analysis

PATH stock trades at a P/E ratio of 20.49, above the software infrastructure sector average, reflecting investor expectations for growth. The company generates $3.01 in revenue per share and $0.52 in earnings per share, with a strong 83.2% gross margin demonstrating pricing power. Free cash flow per share of $0.66 supports the company’s ability to invest in AI integration and product development.

Key Financial Strengths

UiPath maintains a healthy current ratio of 2.48, indicating strong liquidity to fund operations and R&D. The debt-to-equity ratio of 0.034 shows minimal leverage, providing financial flexibility. Return on equity of 15.3% and return on assets of 8.9% demonstrate efficient capital deployment. These metrics position PATH stock as a financially stable player in the competitive automation software market.

AI Integration and Competitive Positioning

UiPath’s platform combines artificial intelligence with robotic process automation (RPA), creating a moat against pure-play AI competitors. The company’s low-code development environment enables enterprise customers to build automation without coding expertise. Recent analyst coverage highlights that AI doesn’t replace UiPath’s automation platform; rather, AI needs it for enterprise deployment at scale.

Growth Drivers and Market Opportunity

Revenue growth of 9.3% year-over-year and net income growth of 18% show PATH stock benefiting from digital transformation trends. The company serves banking, healthcare, financial services, and government sectors, providing diversified revenue streams. With 3,868 employees and a global presence, UiPath is positioned to capture expanding automation demand. You can track PATH on Meyka for real-time updates on analyst sentiment and technical signals.

Analyst Consensus and Price Forecasts

Meyka AI rates PATH with a grade of B+, reflecting balanced risk-reward dynamics. The consensus rating from 15 analysts is Hold, with 2 Buy ratings, 12 Hold ratings, and 1 Sell rating. The average price target of $14.07 implies 32% upside from current levels, though this assumes macro headwinds ease.

Forward-Looking Projections

Meyka AI’s forecast model projects PATH stock reaching $14.15 in 12 months, suggesting recovery potential as earnings growth accelerates. The three-year forecast of $13.13 reflects cautious optimism about long-term automation adoption. Earnings are scheduled for May 28, 2026, which could provide catalysts for re-rating. Forecasts are model-based projections and not guarantees. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Advertisement

Final Thoughts

UiPath Inc. (PATH) trades at $10.66 in pre-market, down 1.2%, as investors balance strong fundamentals against macro uncertainty. The company’s B+ grade from Meyka AI reflects solid financial health, with 83% gross margins, minimal debt, and 15% return on equity. Institutional ownership of 62.5% provides stability, though elevated short interest signals near-term caution. With earnings due May 28 and analyst price targets suggesting 32% upside potential, PATH stock offers a compelling risk-reward for long-term automation investors. The integration of AI into UiPath’s platform positions the company well for sustained growth in enterprise automation markets.

FAQs

Why is PATH stock down today in pre-market trading?

PATH stock declined 1.2% to $10.66 due to macro headwinds including Middle East tensions, inflation concerns, and higher interest rates. These factors weigh on software valuations despite UiPath’s strong fundamentals and AI integration capabilities.

What is Meyka AI’s rating for PATH stock?

Meyka AI rates PATH with a B+ grade and a Buy recommendation. This grade reflects strong financial metrics, sector positioning, and growth potential, though it factors in valuation and macro risks. These grades are not guaranteed and we are not financial advisors.

What is the analyst consensus for UiPath (PATH)?

The consensus rating is Hold, with 2 Buy, 12 Hold, and 1 Sell rating from 15 analysts. The average price target is $14.07, implying 32% upside from current levels if macro conditions stabilize.

When is UiPath’s next earnings announcement?

UiPath will report earnings on May 28, 2026, after market close. This earnings date could serve as a catalyst for PATH stock re-rating if the company beats expectations on revenue growth and AI adoption metrics.

Is PATH stock a good buy at $10.66?

PATH stock offers value for long-term investors given its 83% gross margins, minimal debt, and AI-powered automation platform. However, elevated short interest and macro risks warrant caution. Conduct your own research before investing.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)